Anticholinergic agents in asthma and COPD
- 8 March 2006
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 533 (1-3) , 36-39
- https://doi.org/10.1016/j.ejphar.2005.12.072
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Inhalation by Nebulization of Albuterol-Ipratropium Combination (Dey Combination) Is Superior to Either Agent Alone in the Treatment of Chronic Obstructive Pulmonary DiseaseRespiration, 1998
- Ba 679 BR, A novel long-acting anticholinergic bronchodilatorLife Sciences, 1993
- The assessment and treatment of asthma: A conference reportJournal of Allergy and Clinical Immunology, 1990
- Ipratropium BromideNew England Journal of Medicine, 1988
- MASSIVE OVERDOSE OF ATROPINE METHONITRATE WITH ONLY SLIGHT UNTOWARD EFFECTSThe Lancet, 1985
- Role of the Parasympathetic System in Airway Obstruction Due to EmphysemaNew England Journal of Medicine, 1984
- Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation.Thorax, 1984
- Asthma vs. Non-Specific Reversible Airflow Obstruction: Clinical Features and Responsiveness to Anticholinergic DrugsRespiration, 1984
- Influence of age on response to ipratropium and salbutamol in asthma.Thorax, 1981
- A comparison of the bronchodilator activity of Sch 1000 and salbutamolJournal of Allergy and Clinical Immunology, 1977